Show Summary Details
Page of

Screening for congenital anomalies 

Screening for congenital anomalies
Screening for congenital anomalies

Murray Enkin

, Marc J. N. C. Keirse

, James Neilson

, Caroline Crowther

, Lelia Duley

, Ellen Hodnett

, and Justus Hofmeyr

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 03 December 2020

Genetic screening and diagnosis now has a well-established place in modern obstetric care. It should be offered as an option to those women or couples who are deemed to be at significant risk. The potential benefits and potential adverse effects should be made known to them, so that they can make a properly informed choice. The indications for genetic screening require further clarification, including, in particular, surveys of women’s views of the desirability of the screening and of the psychological effects of both positive and negative results. The benefits of earlier exclusion or diagnosis of some fetal disorders afforded by first-trimester chorion villus sampling, as compared with late amniocentesis, must be set against the greater risks of the former. Women considering prenatal diagnosis must be fully informed about the risks and benefits of the alternative procedures.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.